FDA Orange Book
Is there a generic for Amyvid?
Amyvid contains florbetapir f-18. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Amyvid (florbetapir f-18). The Orange Book shows its last listed patent expires April 30, 2027.
Run it in Rivvi
Map Amyvid and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Amyvid products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 10-100ML (13.5-51mCi/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 10-30ML (13.5-51mCi/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 10-50ML (13.5-51mCi/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 10ML (13.5-51mCi/ML) | Discontinued | None | 0 | None |
NDA 202008, held by AVID RADIOPHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Amyvid patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7687052 | April 30, 2027 | Drug substance, Drug product | U-4217 | 202008 |
| 8506929 | April 30, 2027 | Drug substance, Drug product | U-4217 | 202008 |
Amyvid NDC codes
Questions
Is there a generic for Amyvid?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Amyvid (florbetapir f-18). The Orange Book shows its last listed patent expires April 30, 2027.
What is the generic name for Amyvid?
The active ingredient in Amyvid is florbetapir f-18, per the FDA Orange Book.
When does the Amyvid patent expire?
The last patent listed for Amyvid in the Orange Book expires April 30, 2027. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.